Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Asthma | R-HSA-444620 | map05310 | bendroflumethiazide | 4534 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | bendroflumethiazide | 4534 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | bendroflumethiazide | 4534 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | bendroflumethiazide | 4534 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | bendroflumethiazide | 4534 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | fluocinonide | 9642 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | fluocinonide | 9642 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | fluocinonide | 9642 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | fluocinonide | 9642 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | fluocinonide | 9642 | drug-path |
| Asthma | R-HSA-444620 | map05310 | fluocinonide | 9642 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | fluocinonide | 9642 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | fluocinonide | 9642 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | fluocinonide | 9642 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | fluocinonide | 9642 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | fluocinonide | 9642 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | furaltadone | 9553856 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | furaltadone | 9553856 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | furaltadone | 9553856 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | furaltadone | 9553856 | drug-path |